Lilly MB - Search Results

1

Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal.

Shah N, Pang B, Yeoh KG, Thorn S, Chen CS, Lilly MB, Salto-Tellez M. Shah N, et al. Among authors: lilly mb. Eur J Cancer. 2008 Oct;44(15):2144-51. doi: 10.1016/j.ejca.2008.06.044. Epub 2008 Aug 18. Eur J Cancer. 2008. PMID: 18715779 Review.

2

PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.

Nga ME, Swe NN, Chen KT, Shen L, Lilly MB, Chan SP, Salto-Tellez M, Das K. Nga ME, et al. Among authors: lilly mb. Int J Exp Pathol. 2010 Feb;91(1):34-43. doi: 10.1111/j.1365-2613.2009.00673.x. Epub 2009 Oct 28. Int J Exp Pathol. 2010. PMID: 19878356 Free PMC article.

3

A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.

Twardowski PW, Beumer JH, Chen CS, Kraft AS, Chatta GS, Mitsuhashi M, Ye W, Christner SM, Lilly MB. Twardowski PW, et al. Among authors: lilly mb. Anticancer Drugs. 2013 Aug;24(7):743-53. doi: 10.1097/CAD.0b013e328361feb0. Anticancer Drugs. 2013. PMID: 23652277 Free PMC article. Clinical Trial.

4

Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.

Sonpavde G, Agarwal N, Pond GR, Nagy RJ, Nussenzveig RH, Hahn AW, Sartor O, Gourdin TS, Nandagopal L, Ledet EM, Naik G, Armstrong AJ, Wang J, Bilen MA, Gupta S, Grivas P, Pal SK, Lanman RB, Talasaz A, Lilly MB. Sonpavde G, et al. Among authors: lilly mb. Cancer. 2019 May 1;125(9):1459-1469. doi: 10.1002/cncr.31959. Epub 2019 Jan 8. Cancer. 2019. PMID: 30620391 Free article.

5

Varied differentiation responses of human leukemias to bryostatin 1.

Kraft AS, William F, Pettit GR, Lilly MB. Kraft AS, et al. Among authors: lilly mb. Cancer Res. 1989 Mar 1;49(5):1287-93. Cancer Res. 1989. PMID: 2917358

6

Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects.

Ionov Y, Le X, Tunquist BJ, Sweetenham J, Sachs T, Ryder J, Johnson T, Lilly MB, Kraft AS. Ionov Y, et al. Among authors: lilly mb. Anticancer Res. 2003 Jan-Feb;23(1A):167-78. Anticancer Res. 2003. PMID: 12680209

7

Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase.

Holder S, Zemskova M, Zhang C, Tabrizizad M, Bremer R, Neidigh JW, Lilly MB. Holder S, et al. Among authors: lilly mb. Mol Cancer Ther. 2007 Jan;6(1):163-72. doi: 10.1158/1535-7163.MCT-06-0397. Epub 2007 Jan 11. Mol Cancer Ther. 2007. PMID: 17218638

8

PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.

Zhang F, Beharry ZM, Harris TE, Lilly MB, Smith CD, Mahajan S, Kraft AS. Zhang F, et al. Among authors: lilly mb. Cancer Biol Ther. 2009 May;8(9):846-53. doi: 10.4161/cbt.8.9.8210. Epub 2009 May 18. Cancer Biol Ther. 2009. PMID: 19276681 Free article.

9

p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.

Zemskova M, Lilly MB, Lin YW, Song JH, Kraft AS. Zemskova M, et al. Among authors: lilly mb. Mol Cancer Res. 2010 Aug;8(8):1126-41. doi: 10.1158/1541-7786.MCR-10-0174. Epub 2010 Jul 20. Mol Cancer Res. 2010. PMID: 20647331 Free PMC article.

10

Differentiation and growth modulation of chronic myelogenous leukemia cells by bryostatin.

Lilly M, Tompkins C, Brown C, Pettit G, Kraft A. Lilly M, et al. Cancer Res. 1990 Sep 1;50(17):5520-5. Cancer Res. 1990. PMID: 2386956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters